Cited by 301Tryptophan and brain disordersAutism Spectrum Disorder ResearchNeurotransmitter Receptor Influence on Behavior

Effects of tryptophan depletion in drug-free adults with autistic disorder

McDougle, Christopher·1996·Archives of General Psychiatry

Abstract

BACKGROUND: The primary objective of this study was to investigate the behavioral and biochemical responses to acute tryptophan depletion in drug-free adult patients with autistic disorder. METHODS: Twenty drug-free adults with autistic disorder (16 men and 4 women) (mean [+/- SD] age, 30.5 +/- 8.5 years) underwent short-term tryptophan depletion in a double-blind, placebo-controlled, randomized crossover design. Patients received a 24-hour, low-tryptophan diet followed the next morning by an amino acid drink. Behavioral ratings were obtained on the morning of the amino acid drink (baseline) and 180, 300, and 420 minutes after the drink. Plasma free and total tryptophan levels were obtained at baseline and 5 hours after the drink. The active and sham testing sessions were separated by 7 days. RESULTS: Eleven (65%) of the 17 patients who completed both test days showed a significant global worsening of behavioral symptoms with short-term tryptophan depletion, but none of the 17 patients showed any significant change in clinical status from baseline after sham depletion (P = .001). Tryptophan depletion led to a significant increase in behaviors such as whirling, flapping, pacing, banging and hitting self, rocking, and toe walking (P < .05). In addition, patients were significantly less calm and happy and more anxious. No significant change was observed in social relatedness or repetitive thoughts and behavior. Plasma total and free tryptophan levels were reduced 86% and 69%, respectively, 5 hours after the tryptophan-deficient amino acid drink. Patients who had a significant global exacerbation of symptoms had significantly higher baseline plasma total tryptophan levels (P < .001) and Autism Behavior Checklist scores (P = .005) than did patients who showed no significant change in symptoms after tryptophan depletion. CONCLUSIONS: The results of this study are consistent with previous research that has implicated a dysregulation in serotonin function in some patients with autism. These data suggest that the short-term reduction of serotonin precursor availability may exacerbate some symptoms characteristic of autism in some patients. Continued investigation into the role of serotonin in the pathogenesis and treatment of autistic disorder is warranted.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1996.01830110029004

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Data show decreased capacity for 5-HT synthesis in children with ASD and reports show worsening in repetitive behaviors after tryptophan depletion.

    “This corresponds to data showing decreased capacity for 5′-HT synthesis in children with ASD as well as to reports showing a worsening in repetitive behaviors in individuals with ASD after tryptophan depletion [191,199].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
McDougle, C.
Affiliations
Connecticut Mental Health Center (US)
Corresponding author
McDougle, Christopher
Venue
Archives of General Psychiatry
Published
1996-11-01
Volume
53
Issue
11
Pages
993
ISSN
0003-990X (ISSN-L)
OpenAlex
W2149174165
Cited by
301
References
58
Citations by year
2026: 1 · 2025: 2 · 2024: 9 · 2023: 6 · 2022: 8 · 2021: 6 · 2020: 14 · 2019: 8 · 2018: 9 · 2017: 11 · 2016: 7 · 2015: 20 · 2014: 20 · 2013: 14 · 2012: 9
FWCI
6.25
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of General Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5p50mh030929-14)
  • National Institute of Mental Health (P50 MH30929-18)
  • National Center for Research Resources (M01RR006022, M01 RR06022-33)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 03008-27, P01HD003008)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
tryptophan depletion, autism spectrum disorder, autistic disorder, serotonin, plasma tryptophan, behavioral symptoms, autistic adults, autism pathogenesis
MeSH terms
Adult, Amino Acids, Essential, Autistic Disorder, Child, Double-Blind Method, Female, Humans, Male, Placebos, Psychiatric Status Rating Scales, Serotonin, Severity of Illness Index, Tryptophan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review